Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials
Mikhail Kosiborod, John Deanfield(University College London), Richard Pratley(Translational Research Institute for Metabolism and Diabetes), Barry A. Borlaug(Mayo Clinic in Arizona), Javed Butler, Melanie J. Davies(National Institute for Health Research), Scott S. Emerson(University of Washington), Steven E. Kahn, Dalane W. Kitzman(Wake Forest University), Ildiko Lingvay(The University of Texas Southwestern Medical Center), Kenneth W. Mahaffey(Stanford Medicine), Mark C. Petrie(University of Glasgow), Jorge Plutzky(Harvard University), Søren Rasmussen(Novo Nordisk (Denmark)), Cecilia Rönnbäck(Novo Nordisk (Denmark)), Sanjiv J. Shah(Northwestern University), Subodh Verma(University of Toronto), Peter Weeke(Novo Nordisk (Denmark)), A. Michael Lincoff(Cleveland Clinic Lerner College of Medicine)
Cited by 253
Abstract
Related Papers
No related papers found
Powered by citation graph analysis